Metraipolis › archive › dc_86a137e25500
Antecedent glucagon-like peptide-1 receptor agonist use and risk of sepsis-induced cardiomyopathy in type 2 diabetes: a United States real-world… — Europe PMC PMID:42601938
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42601938
- DOI
- 10.3389/fphar.2026.1877392
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-17T06:51:34.166Z
- SHA-256 of the archived text
70a825ccc338027dad67b21aa9f23bdd0ba16863a5919c37291ed9e3f92fb228- Stable URL of this page
https://metraipolis.com/documento/dc_86a137e25500
How to cite
Antecedent glucagon-like peptide-1 receptor agonist use and risk of sepsis-induced cardiomyopathy in type 2 diabetes: a United States real-world… — Europe PMC PMID:42601938 — Europe PMC (en), https://europepmc.org/article/MED/42601938 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_86a137e25500 (Metraipolis archive dc_86a137e25500, sha256 70a825ccc338027dad67b21aa9f23bdd0ba16863a5919c37291ed9e3f92fb228)
BibTeX
@misc{dc86a137e25500,
title = {Antecedent glucagon-like peptide-1 receptor agonist use and risk of sepsis-induced cardiomyopathy in type 2 diabetes: a United States real-world… — Europe PMC PMID:42601938},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42601938},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_86a137e25500; sha256 70a825ccc338027dad67b21aa9f23bdd0ba16863a5919c37291ed9e3f92fb228},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42601938. Agents can read the archived copy with the MCP tool read_document.